Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Department of Neurosurgery, Massachusetts General Hospital, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
PLoS One. 2019 Jun 13;14(6):e0217939. doi: 10.1371/journal.pone.0217939. eCollection 2019.
Anesthesiologists at our hospital commonly administer spinal anesthesia for routine lumbar spine surgeries. Anecdotal impressions suggested that patients received fewer anesthesia-administered intravenous medications, including vasopressors, during spinal versus general anesthesia. We hypothesized that data review would confirm these impressions. The objective was to test this hypothesis by comparing specific elements of spinal versus general anesthesia for 1-2 level open lumbar spine procedures.
Retrospective single institutional study.
Academic medical center, operating rooms.
Consecutive patients (144 spinal and 619 general anesthesia) identified by automatic structured query of our electronic anesthesia record undergoing lumbar decompression, foraminotomy or microdiscectomy by one surgeon under general or spinal anesthesia.
Spinal or general anesthesia.
Numbers of medications administered during the case.
Anesthesiologists administered in the operating room a total of 10 ± 2 intravenous medications for general anesthetics and 5 ± 2 medications for spinal anesthetics (-5, 95% CI -5 to -4, p<0.001, univariate analysis). Multivariable analysis supported this finding (spinal versus general anesthesia: -4, 95% CI -5 to -4, p<0.001). Spinal anesthesia patients were less likely to receive ephedrine, or phenylephrine (by bolus or by infusion) (all p<0.001, Chi-squared test). Spinal anesthesia patients were also less likely to receive labetolol or esmolol (both p = 0.002, Fishers' Exact test). No neurologic injuries were attributed to, or masked by, spinal anesthesia. Three spinal anesthetics failed.
For routine lumbar surgery in our cohort, spinal compared to general anesthesia was associated with significantly fewer drugs administered during a case and less frequent use of vasoactive agents. Safety implications include greater hemodynamic stability with spinal anesthesia along with reduced risks for medication error and transmission of pathogens associated with medication administration.
我院麻醉师通常为常规腰椎手术施行椎管内麻醉。据传闻,与全身麻醉相比,接受椎管内麻醉的患者接受的麻醉静脉药物(包括升压药)更少。我们假设数据审查将证实这些印象。本研究旨在通过比较 1-2 节开放腰椎手术中椎管内麻醉与全身麻醉的具体要素来验证这一假设。
回顾性单机构研究。
学术医疗中心,手术室。
由一名外科医生在全身麻醉或椎管内麻醉下进行腰椎减压、椎间孔切开术或微创手术的连续患者(椎管内麻醉组 144 例,全身麻醉组 619 例),通过我们的电子麻醉记录的自动结构化查询确定。
椎管内麻醉或全身麻醉。
手术期间给予的药物数量。
麻醉师在手术室共给予全身麻醉 10±2 种静脉药物,椎管内麻醉 5±2 种药物(-5,95%CI-5 至-4,p<0.001,单变量分析)。多变量分析支持这一发现(椎管内麻醉与全身麻醉:-4,95%CI-5 至-4,p<0.001)。与全身麻醉相比,椎管内麻醉患者接受麻黄碱或苯肾上腺素(推注或输注)的可能性更小(均 p<0.001,卡方检验)。椎管内麻醉患者也较少接受拉贝洛尔或艾司洛尔(均 p=0.002,Fisher 精确检验)。没有神经损伤归因于或被椎管内麻醉掩盖。3 例椎管内麻醉失败。
在我们的队列中,对于常规腰椎手术,与全身麻醉相比,椎管内麻醉与术中给予的药物数量显著减少,血管活性药物的使用频率也较低。安全性影响包括椎管内麻醉时更稳定的血液动力学和降低药物管理相关的药物错误和病原体传播风险。